1981
DOI: 10.1002/lipi.19810830308
|View full text |Cite
|
Sign up to set email alerts
|

Welche Akzeptorphase ist am ehesten repräsentativ für die Hornschicht bei in vitro‐Messungen der Wirkstoffabgabe aus Externa?

Abstract: The seeds of Brassica sp. are known to have characteristic sterol composition in containing a larger amount of brassicastero12e72*, and the finding in this study of trans-22-dehydrocholesterol and stigmasta-5,25-dienol, which are regarded indeed as the natural products rather than the artefacts, in B. napus seed oil is of interest from the standpoint of sterol biogenesis.N o m e n c l a t u r e "Campesterol" is a mixture of 24a-and 24fi-methylcholesterol 28, and "campestanol" described here is con-*% W . R. Ne… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

1982
1982
2000
2000

Publication Types

Select...
3
2

Relationship

1
4

Authors

Journals

citations
Cited by 5 publications
(1 citation statement)
references
References 3 publications
0
1
0
Order By: Relevance
“…It corresponds to the sebaceous gland secretion [5], Another example are the keratoplastic drugs like salicylic acid. Our investigations comparing in vitro drug release with in vivo studies revealed that a li pophilic acceptor medium is most represen tative for the physiologic acceptor medium [6], A topical effect is also the aim of antimicrobial therapy for mycotic or bacte rial skin infections. Here the acceptor medium must be differently characterized depending on whether oozing skin altera tions or hyperkeratosis prevails.…”
Section: Discussionmentioning
confidence: 99%
“…It corresponds to the sebaceous gland secretion [5], Another example are the keratoplastic drugs like salicylic acid. Our investigations comparing in vitro drug release with in vivo studies revealed that a li pophilic acceptor medium is most represen tative for the physiologic acceptor medium [6], A topical effect is also the aim of antimicrobial therapy for mycotic or bacte rial skin infections. Here the acceptor medium must be differently characterized depending on whether oozing skin altera tions or hyperkeratosis prevails.…”
Section: Discussionmentioning
confidence: 99%